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The World Health Organization reported 
that 40% of the pregnancies in the world in 
1977 were unplanned and 20% were un­
wanted; in the United States in 1978 there were 
1,300,000 teenage pregnancies, of which one 
million ended in abortions To prevent these un­
wanted pregnancies and also to abolish the 
cost in terms of money, time and lives, concep­
tion control is very important Contraception is 
as old as the human race. In ancient times Chi­
nese women swallowed live tadpoles three days 
atter their menses for this purpose. North Afri­
can women mixed gunpowder solution and 
loam from a camel's mouth and drank the re­
sulting potion. Egyptian women inserted pes­
saries made of crocodile dung to achieve con­
traception. Greek women in the second century 
made a vaginal plug that contained oil, honey, 
cedar gum and fig pulp; others ate the uterus of 
female mules. As recently as the 17th century, 
European brides were instructed to sit on their 
lingers while riding in coaches or to place 
roasted walnuts in their bosoms, one for every 
barren year desired. Obviously, an unwanted 
child was of as much concern to the ancients as 
it is to modern women. 
These are the characteristics of an ideal 
contraceptive: 
1 . 1 00% effective 
2. Sale with no side effects 
3. Simple to use 
The following is an edited transcript of remarks by Dr. 
Kumarasamy at the 51 st Annual McGuire Lecture Series, 
October 19, 1979. at the Medical College of Virginia, Rich­
mond, Virginia. 
Correspcndence and reprint requests to Dr. Thampu 
Kumarasamy, Box 34. Medical College of Virginia, Rich­
mond, VA 23298. 
4 Inexpensive 
5. Removed from the act of intercourse 
6. Completely reversible 
7. Easily available 
There are two types of effectiveness­
theoretical effectiveness and use effectiveness. 
Use effectiveness is invariably found to be lower 
than theoretical effectiveness. 
The varieties of contraceptive methods 
available are 
1. Chance 
2. Douching 
3. The rhythm method 
4. Use of spermicides 
5. Condoms 
6. Diaphrams 
7. Condoms and spermicides or dia­
phram and spermicides 
8. Oral contraceptives, which can be a 
combined oral contraceptive or pro­
gestin-only (minipill) 
9. Injectable contraceptives 
10. Intrauterine contraceptives 
11 . Male sterilization 
1 2. Female sterilization 
Of these, chance and douching have the 
lowest rate of effectiveness, and the rhythm 
method, or the so called "sale period," sup­
posedly one week before and one week after 
the first day of menses, should not be consid­
ered as particularly sale. 
Condoms 
Condoms have been in use since the 1 7th 
century both to prevent venereal disease and to 
avoid impregnating women. Today, in the 
United States, 700 to 800 million condoms are 
produced annually. Condoms may be a prob-
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lem for men with borderline impotence or those 
who cannot maintain an erection for some time. 
The earlier objections to the use of condoms, 
such as decrease in thermal and/or tactile sen­
sitivity have been overcome by the manufacture 
of condoms made of very thin but strong mate­
rial. In Japan, the most commonly used con­
traceptive agent is the condom. Recently, the 
International Planned Parenthood Federation 
has reported that condoms and spermicides 
used in con1unction by motivated people are as 
effective as oral contraceptives. Those con­
cerned about the use of oral contraceptives and 
their complications or the complications of intra­
uterine devices, can use condoms and spermi­
cides. And condoms have the distinct advan­
tage of preventing the spread of venereal 
disease. 
Oral Contraceptives 
The types of oral contraceptives are 1 ) the 
combination pill, 2) the progestin-only (minipill), 
and 3) the morning after pill. The mechanism of 
action of the combination pill is supposed to be 
a combination of the following: 
1 . Prevention of ovulation 
2. Some alteration of tubal transport 
3. Changes in the endometrium 
4. Alteration of the cervical mucus 
Symptoms attributed to estrogens in the 
combination pill are: 
1 . Nausea and bloating 
2. Cyclic weight gain and/or edema 
3. Nervousness, irritability and/or pre-
menstrual tension 
4. Venous or capillary engorgement 
5. Headache 
6. Breast tenderness or cystic changes 
7. Mucorrhea, cervical erosion or polypo­
sis 
8. Hypermenorrhea 
9. Dysmenorrhea 
1 0. Fibroid growth 
1 1 . Changes in carbohydrate metabolism 
1 2. Hypertension 
13. Thrombophlebitis 
1 4. Suppression of lactation 
Symptoms related to progestins are: 
1 . Amenorrhea or oligomenorrhea 
2. Acne 
3. Hirsutism 
4 Increased appetite and steady weight 
gain 
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5. Depression and changes in libido 
6. Fatigue 
7. Moniliasis 
8. Early spotting and breakthrough 
bleeding 
9. Oily scalp and loss of hair 
Side effects of oral contraceptives are: 
1 . Nausea and vomiting 
2. Weight gain 
3. Spotting and breakthrough bleeding 
4. Headache 
5. Nervousness and irritability 
6. Depression 
7. Loss of libido 
8. Breast discomfort 
9. Acne 
10. Melasma 
11 Amenorrhea 
1 2. Thromboembolic effects 
There is some concern that oral con­
traceptives may be responsible for genetic 
changes and some forms of cancer. So far: 
there is no definite evidence to support the idea 
of genetic changes, and no association, ad­
verse or beneficial, between the use of oral con­
traceptives and the development of cancer of 
the breasts, endometrium, or cervix, according 
to current data. Long-term combined oral con­
traceptive use appears to be related to the de-' 
velopment of benign liver neop\asia. There is 
also evidence that oral contraceptives may have 
an adverse influence on the resolution of hyda­
tidiform mole. 
ABSOLUTE CONTRAINOICA TIONS TO THE USE OF THE 
PILL 
Thrombophlebitis, thromboembolic 
disorders, cerebrovascular disease, or 
a past history of these conditions 
2. Markedly impaired liver function 
3. Known or suspected carcinoma of the 
breast 
4. Known or suspected estrogen-depen­
dent neoplasia 
5. Undiagnosed abdominal genital bleed-
ing 
6. Known or suspected pregnancy 
7 Congenital hyperlipidemia 
8. Gestational diabetes 
9. Progressive heart disease 
1 0 Progressive high blood pressure 
Some relative but not absolute con­
traindications are: 
1. Obesity 
2. Headache 
3. Fibroids 
The progestin-dominant pill is suitable for 
a woman if she should have: 
1 . Excessive outpouring of leukorrhea 
2. A generalized sense of bloating or 
nausea while taking a contraceptive 
with high estrogen component 
3. A tendency toward fluid retention and 
premenstrual weight gain 
4. A degree of emotional instability and 
irritability prior to the menses 
5. Excessive menstrual flow 
6. More than the average amount of fi­
brocystic disease and a tendency to­
wards swollen, tender breasts and nip­
ples 
Women experiencing the following are not 
good candidates for progestin-dominant con­
traceptives: 
1 . Hirsutism and acne 
2. Underdevelopment of breasts 
3. Very scanty menstrual flow or a fore­
shortened cycle 
4. Increasing appetite and steady weight 
gain 
5. Varying degrees of depression in the 
menstrual cycle 
6. Excess weight gain during previous 
pregnancy 
7. Intermittent depression or loss of libido 
8. Breakthrough bleeding 
THE MINIPILL 
This is a progestin-only preparation which, 
when taken as directed, is an effective oral con­
traceptive-, although it is less effective than an 
estrogen-progestin combination. The prepara­
tions available are Micronor, Nor-0.D., and Ov­
rette. The anticonception effect is due to a com­
bination of poor endocervical mucus preventing 
sperm penetration in addition to the endometrial 
changes that are out of sequence for proper im­
plantation of the blastocyst. There is also an ef­
fect on tubal motility and the enzymes in the 
endosalpinges. Presently, the majority of 
women using the minipill continue to ovulate. 
These pills are administered on a continuous 
daily basis, starting on the first day of men­
struation. The minipill seems to be perfect for 
women who cannot tolerate the combined prep-
arations because of excessive side effects such 
as nausea, weight gain and mastalgia. 
Intrauterine Contraceptive Devices 
Stoning the camel was a practice that 
dates back to ancient Egyptians who introduced 
a small oval stone into the uterine cavity of fe­
male camels to prevent them from becoming 
pregnant if they were to be used for long jour­
neys across the desert. 
Very much later, Pust, a German gynecol­
.:>gist, designed a number of cervical stem pes­
saries made of glass, a combination of metals 
and a silkworm, and used them to treat dys­
menorrhea when associated with an acutely 
antiflexed uterus. It was observed that these 
pessaries acted as contraceptives. Another 
German gynecologist, Ernst Grafenberg, elimi­
nated the part of the appliance that lay in the 
cervical canal and produced his now well­
known ring made of coiled silver wire. 
The Japanese were the first to make and 
use plastic devices, and today the following de­
vices are available for clinical use: 
1. Saf-T-Coil 
2. Lippes loop 
3. Copper-? 
4. Copper-T or Tatum-T 
5. Progestasert 
The mechanism of action of intrauterine 
contraceptive devices is not very clear. The the­
ory that increased tubal and uterine motility 
causes the fertilized egg to reach the endome­
trium before the conditions are favorable for im­
plantation has not been substa,ntiated. It is also 
believed that the inflammatory and immune re­
action within the endometrium may cause prob­
lems of implantation of the blastocyst. 
The action of copper in copper-impreg­
nated intrauterine devices is believed to be due 
to its interference with the migration of sperma­
tazoa as well as with implantation, probably by 
disrupting the sulphydryl groups in the endome­
trium and in the spermatazoa. 
HISTOLOGICAL CHANGES 
The effects of intrauterine contraceptive 
devices on the endometrium have been well 
studied in human beings. The most obvious 
changes are 1 ) an increase in the number and 
size of vascular channels, 2) a diffuse or patchy 
subsurface stromal hemorrhage, and 3) 
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changes in the amount and distribution of fluid 
in the endometrial stroma 
ADVANTAGES OF THE INTRAUTERINE DEVICE 
1 . The greatest advantage is that once 
the device is in place, no further moti­
vation, effort or treatment is required 
for continued contraception 
2. It is especially useful for those who 
have trouble following directions or re­
membering to use any other method 
3. There is a lack of systemic effects 
4. It may be most suitable for older 
women 
DISADVANTAGES OF THE INTRAUTERINE DEVICE 
1 Pain and difficulty associated with in­
sertion 
2. Side effects of cramps and bleeding 
and vasovagal reaction 
3. Failure (2% to 5% pregnancy rate) 
COMPLICATIONS OF THE INTRAUTERIN DEVICE 
1 Bleeding 
2. Pregnancy 
3. Expulsion 
4. Pain 
5. Perforation 
6. Infection 
7 Fracture of the device or loss of the 
string attached to the intrauterine de­
vice 
CONTRAINDICATIONS 
1 . Severe dysmenorrhea 
2. Menorrhagia 
3. Pelvic infection, recent or chronic 
4. Perimenopausal menstrual abnormal­
ity 
5. Congenital anomalies of the uterus 
6. Some women with fibroids 
Surgical Sterilization 
The use of sterilizing procedures is in­
creasing world wide. In the male, vasectomy is 
simple, sale and effective, but has the mild dis­
advantage of not being immediately effective. 
On the other hand, in the female, the tubal liga­
tion involves no measurable risk to life, can be 
done as an outpatient procedure, and is imme­
diately effective. Tubal sterilization in the female 
can be performed in the postpartum period or 
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as an interval procedure. The routes by whic� 
this procedure can be performed are via the ab­
dominal wall, via the posterior lornix of the Vi3-
gina, or by the use of a laparoscope or hys­
teroscope. Though the use of the laparoscope 
for tubal sterilization procedures has gained 
wide acceptance and popularity, the mini­
laparotomy is as safe and quick and effective iri 
selected females and has the additional advan­
tage of low cost. 
Damage to the tubes caused by coagu­
lation or cauterization via the laparoscope not 
only damages extensive areas of the tube ana 
the broad ligament, but also may cause some 
ovarian dysfunction leading to post-sterilizatiori 
problems of pain and bleeding On the other· 
hand, use of mechanical devices to occlude the 
fallopian tube such as the use of silicone rubber 
bands or plastic clips has been shown to mini­
mize the above-mentioned postoperative symp-· 
tomatology. Because the mechanical devices 
produce minimal damage to the fallopian tubes 
this method is most suitable for a young woman 
who may request tubal reanastomosis at a later 
stage. 
To date, we do not have a single revers­
ible method of sterilization. Any surgical steril­
ization method is designed to be permanent 
and tubal occlusion procedures are accepted 
as the preferred procedure for those women 
who have definitely completed their child­
bearing and who desire sterilization. Should any 
uterine pathology and/or symptomatology of 
significance be found. then hysterectomy is ac­
ceptable and fully justified as a sterilization pro­
cedure. 
Overall. from my experience. I would ad­
vise the following as the best forms of con­
traception for the various categories of women: 
Unmarried teenagers 
1. Abstinence through education and 
self-control 
2. Condoms and spermicides 
3. Diaphram and spermicides 
4. Oral contraceptives 
Married women 
1 . Condoms and spermicides 
2. Diaphrams and spermicides 
3. Oral contraceptives 
4 Intrauterine contraceptive devices 
5. Tubal occlusion by a method that 
would result in minimal damage to the 
tubes. Example: clips, bipolar cautery 
or Falope rings 
6. Hysterectomy only if uterine pathology 
of significance exists 
Women over 35 
1 _ Diaphram and spermicides or con-
doms and spermicides 
2 _ Intrauterine contraceptive devices 
3. Tubal occlusion 
4. Hysterectomy if uterine pathology or 
symptomatology of significance exists 
Preabortal women 
1 _ Suction dilatation and curettage fol­
lowed by tubal occlusion 
2. Saline abonion followed by tubal oc­
clusion 
3. Abortion-hysterectomy if, in addition, 
any uterine pathology is found 
Postabortal women who desire further fertility 
1 Barrier methods 
2 _ Oral contraception 
3 Intrauterine devices 
Postpartum women 
1 Use of condoms and spermicides 
2. Oral contraceptives 
3 _ Intrauterine devices 
4 Tubal occlusion 
KUMARASAMY CONTRACEPTION VS STERILIZATION / 31 
